Multivariable model integrating PHI and mpMRI for detecting csPCa in biopsy‐naïve men
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Mario Dominguez Esteban, Ester Fernandez Guzman, Enrique Ramos Barselo, Ernesto Herrero Blanco, Sergio Zubillaga Guerrero, Roberto Ballestero Diego, Alejandro Fernandez Florez, Jose Javier Gomez Roman, Jaime Garcia Herrero, Marina Sanchez Gil, Guillermo Velilla Diez, Felix Campos Juanatey, Maria Teresa Garcia Unzueta, Jose Luis Gutierrez Baños |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
por: Joshua Yi Min Tung, et al.
Publicado: (2026)
por: Joshua Yi Min Tung, et al.
Publicado: (2026)
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024)
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
por: Esther H. J. Hamoen, et al.
Publicado: (2025)
por: Esther H. J. Hamoen, et al.
Publicado: (2025)
The impact of biopsy core length on the discrepancy in Gleason scores between biopsy and radical prostatectomy specimen
por: Cheng‐hao Guo, et al.
Publicado: (2025)
por: Cheng‐hao Guo, et al.
Publicado: (2025)
The carbon footprint of transperineal prostate biopsy
por: Daniel A. Carson, et al.
Publicado: (2025)
por: Daniel A. Carson, et al.
Publicado: (2025)
Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
por: Yuki Teramoto, et al.
Publicado: (2026)
por: Yuki Teramoto, et al.
Publicado: (2026)
Expert consensus on Rezūm™: Indications, surgical technique and postoperative care
por: Emilio López Alcina, et al.
Publicado: (2025)
por: Emilio López Alcina, et al.
Publicado: (2025)
Multiparametric‐magnetic resonance imaging (mp‐MRI) of the prostate and Urolift: Identifying artefact size, location and clinical implications
por: Cameron James Parkin, et al.
Publicado: (2024)
por: Cameron James Parkin, et al.
Publicado: (2024)
Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
por: Maxwell Louis Sandberg, et al.
Publicado: (2026)
por: Maxwell Louis Sandberg, et al.
Publicado: (2026)
A modified Delphi consensus statement on the role of biopsy in small renal masses
por: Darryl E. Bernstein, et al.
Publicado: (2025)
por: Darryl E. Bernstein, et al.
Publicado: (2025)
Risk factors of negative prostate biopsies: A CHAID decision tree analysis
por: Pierre Allainguillaume, et al.
Publicado: (2026)
por: Pierre Allainguillaume, et al.
Publicado: (2026)
AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
por: Muhammad Imran, et al.
Publicado: (2026)
por: Muhammad Imran, et al.
Publicado: (2026)
Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta‐analysis
por: Sean Lim, et al.
Publicado: (2024)
por: Sean Lim, et al.
Publicado: (2024)
Contemporary assessment of diagnostic performance and histologic concordance of renal mass biopsy with surgical pathology
por: Mitchell M. Huang, et al.
Publicado: (2025)
por: Mitchell M. Huang, et al.
Publicado: (2025)
Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
por: Agnieszka Krzyzanowska, et al.
Publicado: (2024)
por: Agnieszka Krzyzanowska, et al.
Publicado: (2024)
Transperineal prostate biopsy with freehand technique under local anaesthetic: A systematic review and meta‐analysis
por: Benjamin M. Mac Curtain, et al.
Publicado: (2025)
por: Benjamin M. Mac Curtain, et al.
Publicado: (2025)
The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
por: Abel Tesfai, et al.
Publicado: (2024)
por: Abel Tesfai, et al.
Publicado: (2024)
Concordance with final pathology when transitioning from standard transrectal to cognitive targeted transperineal prostate biopsy
por: Alfred Honoré, et al.
Publicado: (2025)
por: Alfred Honoré, et al.
Publicado: (2025)
Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
por: Sofia Mesquita, et al.
Publicado: (2025)
por: Sofia Mesquita, et al.
Publicado: (2025)
Outcomes following intradetrusor onabotulinumtoxinA injections and sacral neuromodulation in older men
por: Leo D. Dreyfuss, et al.
Publicado: (2026)
por: Leo D. Dreyfuss, et al.
Publicado: (2026)
Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
por: Stijn M. van den Bosch, et al.
Publicado: (2026)
por: Stijn M. van den Bosch, et al.
Publicado: (2026)
Potential gains from radical treatment of men with prostate cancer according to life expectancy
por: Sandra Irenaeus, et al.
Publicado: (2025)
por: Sandra Irenaeus, et al.
Publicado: (2025)
Outcome of post‐prostatectomy stress urinary incontinence surgery in men with preoperative idiopathic detrusor overactivity
por: Nikita R. Bhatt, et al.
Publicado: (2024)
por: Nikita R. Bhatt, et al.
Publicado: (2024)
Targeted Prostate Health Checks, a novel system to identify men with prostate cancer—A pilot study
por: Stephen Langley, et al.
Publicado: (2024)
por: Stephen Langley, et al.
Publicado: (2024)
Robotic‐assisted approaches to urachal carcinoma: A comprehensive systematic review of the safety and efficacy outcomes
por: Caio Vinícius Suartz, et al.
Publicado: (2024)
por: Caio Vinícius Suartz, et al.
Publicado: (2024)
Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow‐up analysis of the COVIDSurg‐Cancer study
por: Arjun Nathan, et al.
Publicado: (2024)
por: Arjun Nathan, et al.
Publicado: (2024)
Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
por: Cameron E. Alexander, et al.
Publicado: (2024)
por: Cameron E. Alexander, et al.
Publicado: (2024)
Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
por: Mathew Thakur, et al.
Publicado: (2024)
por: Mathew Thakur, et al.
Publicado: (2024)
Giant testicular germ‐cell tumours—An analysis of relative incidence and clinical features based on a clinical case series and a survey of the literature
por: Markus Angerer, et al.
Publicado: (2026)
por: Markus Angerer, et al.
Publicado: (2026)
Prognostic factors and treatment impact on overall survival in patients with renal neuroendocrine tumour
por: Olamide O. Omidele, et al.
Publicado: (2024)
por: Olamide O. Omidele, et al.
Publicado: (2024)
Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort
por: Goran Bencina, et al.
Publicado: (2024)
por: Goran Bencina, et al.
Publicado: (2024)
Prevention of lymphoceles using peritoneal flaps during robotic‐assisted radical prostatectomy with pelvic lymph node dissection: A systematic review and meta‐analysis
por: Huseyin Yildiz, et al.
Publicado: (2026)
por: Huseyin Yildiz, et al.
Publicado: (2026)
Treatment decision regret after precision prostatectomy: An analysis of patient‐reported outcomes predicting decision regret
por: Kaushik P. Kolanukuduru, et al.
Publicado: (2024)
por: Kaushik P. Kolanukuduru, et al.
Publicado: (2024)
Issue Information
Publicado: (2025)
Publicado: (2025)
Step‐by‐step: A traction‐based fenestration method for vasoepididymostomy
por: Kosuke Kojo, et al.
Publicado: (2025)
por: Kosuke Kojo, et al.
Publicado: (2025)
Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
por: Angelo Porreca, et al.
Publicado: (2025)
por: Angelo Porreca, et al.
Publicado: (2025)
Competing risk of death in patients with low, intermediate and high risk of recurrence after radical surgery for clear cell renal cell carcinoma
por: Anna Brännbäck, et al.
Publicado: (2025)
por: Anna Brännbäck, et al.
Publicado: (2025)
Urinary microbiota diversity and composition in patients with advanced renal cell cancer
por: Frederico Leal, et al.
Publicado: (2026)
por: Frederico Leal, et al.
Publicado: (2026)
Racial and socioeconomic disparities in surgical care for post‐prostate cancer treatment complications: A nationwide Medicare‐based analysis
por: Oluwafolajimi Adesanya, et al.
Publicado: (2024)
por: Oluwafolajimi Adesanya, et al.
Publicado: (2024)
Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
por: Kira Furlano, et al.
Publicado: (2024)
por: Kira Furlano, et al.
Publicado: (2024)
Ejemplares similares
-
Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
por: Joshua Yi Min Tung, et al.
Publicado: (2026) -
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
por: Arjun Pon Avudaiappan, et al.
Publicado: (2024) -
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
por: Esther H. J. Hamoen, et al.
Publicado: (2025) -
The impact of biopsy core length on the discrepancy in Gleason scores between biopsy and radical prostatectomy specimen
por: Cheng‐hao Guo, et al.
Publicado: (2025) -
The carbon footprint of transperineal prostate biopsy
por: Daniel A. Carson, et al.
Publicado: (2025)